Form 4: Nuvalent Executive Darlene Noci Executes Stock Option and Sells Shares

Darlene Noci, Chief Development Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on July 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On July 1, 2024, Darlene Noci, the Chief Development Officer of Nuvalent, Inc., engaged in transactions involving the company's Class A Common Stock.
• Noci exercised a stock option to acquire 5,000 shares at a price of $18.93 per share.
• Concurrently, Noci sold 4,458 shares at a weighted average price of $75.46 and 542 shares at a weighted average price of $76.19.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 21, 2023.
• Following these transactions, Noci directly owns 33,300 shares of Class A Common Stock and holds options for 50,800 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions by an officer under a pre-existing trading plan. There's no inherent positive or negative signal.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any surprise effect.

Key Dates